SUPN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.80%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $16,830,854.81

Supernus Pharmaceuticals Insider Trading History Chart

Supernus Pharmaceuticals Share Price & Price History

^$45.40

▼ -0.62 (-1.35%)

As of 11/10/2025 05:00 PM ET

Days: 30 | 90 | 365

Supernus Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/9/2025	Jack A. Khattar	CEO	Sell	59,900	$50.57	$3,029,143.00	1,206,578
9/29/2025	Jack A. Khattar	CEO	Sell	10,235	$48.02	$491,484.70	1,144,336
9/23/2025	Jack A. Khattar	CEO	Sell	29,513	$47.23	$1,393,898.99	1,140,883
9/22/2025	Jack A. Khattar	CEO	Sell	16,587	$47.02	$779,920.74	1,122,456
9/12/2025	Frank Mottola	SVP	Sell	5,000	$45.87	$229,350.00	15,496
9/8/2025	Jack A. Khattar	CEO	Sell	6,322	$46.29	$292,645.38	1,111,983
9/5/2025	Jack A. Khattar	CEO	Sell	55,578	$46.01	$2,557,143.78	1,110,231
8/25/2025	Frank Mottola	SVP	Sell	14,000	$44.51	$623,140.00	15,496
8/25/2025	Jack A. Khattar	CEO	Sell	1,000	$45.00	$45,000.00	1,071,459
8/22/2025	Timothy C Dec	CFO	Sell	11,780	$44.49	$524,092.20	1,246
8/14/2025	Bethany Sensenig	Director	Sell	5,369	$42.25	$226,840.25
8/14/2025	Frederick M. Hudson	Director	Sell	7,457	$42.26	$315,132.82	46,307
8/6/2025	Jack A. Khattar	CEO	Sell	140,000	$42.02	$5,882,800.00	1,030,183
2/21/2025	Jonathan Rubin	SVP	Sell	927	$39.15	$36,292.05	7,853
2/4/2025	Padmanabh P. Bhatt	VP	Sell	9,477	$39.70	$376,236.90	10,149
1/28/2025	Padmanabh P. Bhatt	VP	Sell	700	$39.62	$27,734.00	10,149
11/7/2024	Frank Mottola	SVP	Sell	15,000	$36.98	$554,700.00	8,200
11/7/2024	Georges Gemayel	Director	Sell	14,213	$36.62	$520,480.06	13,315
11/7/2024	Jack A. Khattar	CEO	Sell	125,000	$36.68	$4,585,000.00	926,172
3/21/2024	Padmanabh P. Bhatt	VP	Sell	14,491	$35.31	$511,677.21	8,570
3/19/2024	Padmanabh P. Bhatt	VP	Sell	12,364	$35.31	$436,572.84	8,570
3/12/2024	Padmanabh P. Bhatt	VP	Sell	3,884	$32.99	$128,133.16	8,570
2/26/2024	Padmanabh P. Bhatt	VP	Sell	5,000	$30.21	$151,050.00	8,570
1/10/2024	Tami Tillotson Martin	VP	Sell	8,000	$27.91	$223,280.00	85,664
11/15/2023	Frederick M. Hudson	Director	Sell	9,093	$28.50	$259,150.50	33,231
11/14/2023	Frank Mottola	SVP	Sell	1,110	$28.13	$31,224.30	5,681
8/30/2023	Tami Tillotson Martin	VP	Sell	8,100	$32.00	$259,200.00	85,249
8/25/2023	Tami Tillotson Martin	VP	Sell	5,135	$31.59	$162,214.65	85,249
3/14/2023	Frank Mottola	SVP	Sell	4,780	$35.99	$172,032.20	4,737
2/2/2023	Jack A. Khattar	CEO	Sell	13,532	$42.05	$569,020.60	804,142
1/31/2023	Jack A. Khattar	CEO	Sell	976	$42.01	$41,001.76	794,961
1/17/2023	Jack A. Khattar	CEO	Sell	25,446	$40.03	$1,018,603.38	791,173
1/17/2023	Padmanabh P. Bhatt	VP	Sell	4,826	$39.92	$192,653.92	1,644
1/6/2023	Padmanabh P. Bhatt	VP	Sell	174	$39.90	$6,942.60	1,644
12/21/2022	Jack A. Khattar	CEO	Sell	11,354	$38.14	$433,041.56	814,699
12/1/2022	Padmanabh P. Bhatt	VP	Sell	5,000	$37.48	$187,400.00	1,644
11/25/2022	Jack A. Khattar	CEO	Sell	11,135	$35.18	$391,729.30	789,434
11/23/2022	Jack A. Khattar	CEO	Sell	2,259	$35.05	$79,177.95	782,775
11/21/2022	Jack A. Khattar	CEO	Sell	531	$35.01	$18,590.31	781,059
11/15/2022	Jack A. Khattar	CEO	Sell	1,115	$35.00	$39,025.00	780,742
11/11/2022	Padmanabh P. Bhatt	VP	Sell	6,800	$34.95	$237,660.00	1,644
11/9/2022	Padmanabh P. Bhatt	VP	Sell	700	$34.97	$24,479.00	1,644

SEC Filings (Institutional Ownership Changes) for Supernus Pharmaceuticals (NASDAQ:SUPN)

Institutional Buying and Selling by Quarter

Supernus Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/10/2025	Villanova Investment Management Co LLC	54,868	$2.62M	1.8%	+4.9%	0.098%
11/10/2025	Ameritas Investment Partners Inc.	4,507	$0.22M	0.0%	-14.2%	0.008%
11/10/2025	Citigroup Inc.	64,716	$3.09M	0.0%	-45.0%	0.115%
11/10/2025	China Universal Asset Management Co. Ltd.	13,429	$0.64M	0.1%	-36.8%	0.024%
11/10/2025	Jupiter Asset Management Ltd.	4,833	$0.23M	0.0%	N/A	0.009%
11/10/2025	Persistent Asset Partners Ltd	5,159	$0.25M	0.2%	N/A	0.009%
11/7/2025	denkapparat Operations GmbH	6,202	$0.30M	0.2%	N/A	0.011%
11/7/2025	Vanguard Group Inc.	6,044,750	$288.88M	0.0%	-2.6%	10.780%
11/7/2025	JPMorgan Chase & Co.	171,285	$8.19M	0.0%	-45.6%	0.305%
11/7/2025	PNC Financial Services Group Inc.	15,558	$0.74M	0.0%	-2.0%	0.028%
11/7/2025	Shell Asset Management Co.	3,026	$0.15M	0.0%	-60.2%	0.005%
11/6/2025	Assetmark Inc.	39,724	$1.90M	0.0%	+8.2%	0.071%
11/6/2025	Public Sector Pension Investment Board	218,684	$10.45M	0.0%	-0.7%	0.390%
11/6/2025	LSV Asset Management	6,100	$0.29M	0.0%	N/A	0.011%
11/6/2025	Rhumbline Advisers	169,802	$8.12M	0.0%	-1.4%	0.303%
11/6/2025	MQS Management LLC	6,852	$0.33M	0.2%	-22.5%	0.012%
11/6/2025	Bryce Point Capital LLC	5,619	$0.27M	0.3%	N/A	0.010%
11/6/2025	ProShare Advisors LLC	12,198	$0.58M	0.0%	-13.9%	0.022%
11/5/2025	AdvisorShares Investments LLC	15,525	$0.74M	0.1%	N/A	0.028%
11/5/2025	Smartleaf Asset Management LLC	1,137	$54K	0.0%	+30.8%	0.002%
11/5/2025	Castlekeep Investment Advisors LLC	50,130	$2.40M	1.1%	+25.1%	0.089%
11/5/2025	Envestnet Asset Management Inc.	27,012	$1.29M	0.0%	-70.2%	0.048%
11/5/2025	Hantz Financial Services Inc.	625	$30K	0.0%	+81.7%	0.001%
11/4/2025	State of Wyoming	1,423	$68K	0.0%	N/A	0.003%
11/4/2025	Principal Financial Group Inc.	303,408	$14.50M	0.0%	-0.7%	0.541%
11/4/2025	Thrivent Financial for Lutherans	40,993	$1.96M	0.0%	-0.4%	0.073%
11/3/2025	AlphaQuest LLC	25,836	$1.24M	0.1%	+15.4%	0.046%
11/3/2025	Arizona State Retirement System	16,547	$0.79M	0.0%	+1.7%	0.030%
11/3/2025	Summit Global Investments	4,209	$0.20M	0.0%	N/A	0.008%
11/3/2025	Ruffer LLP	55,385	$2.65M	0.1%	N/A	0.099%
11/3/2025	Great Lakes Advisors LLC	71,231	$3.40M	0.0%	-49.9%	0.127%
11/3/2025	New York State Common Retirement Fund	33,318	$1.59M	0.0%	-11.9%	0.059%
11/3/2025	Mirae Asset Global Investments Co. Ltd.	7,472	$0.36M	0.0%	+245.4%	0.013%
11/3/2025	Federated Hermes Inc.	2,546	$0.12M	0.0%	+62.0%	0.005%
10/31/2025	James Investment Research Inc.	20,975	$1M	0.1%	+18.9%	0.037%
10/31/2025	Mutual of America Capital Management LLC	199,259	$9.52M	0.1%	-6.3%	0.355%
10/30/2025	Teacher Retirement System of Texas	112,638	$5.38M	0.0%	+648.9%	0.201%
10/30/2025	Covestor Ltd	2,309	$0.11M	0.1%	+29.6%	0.004%
10/30/2025	VELA Investment Management LLC	40,251	$1.92M	0.5%	N/A	0.072%
10/30/2025	Universal Beteiligungs und Servicegesellschaft mbH	109,836	$5.25M	0.0%	+28.4%	0.196%
10/29/2025	Amalgamated Bank	16,030	$0.77M	0.0%	+2.0%	0.029%
10/29/2025	Maryland State Retirement & Pension System	8,061	$0.39M	0.0%	-51.0%	0.014%
10/28/2025	QRG Capital Management Inc.	9,714	$0.46M	0.0%	-48.6%	0.017%
10/28/2025	Stephens Investment Management Group LLC	1,345,402	$64.30M	0.8%	-14.9%	2.399%
10/28/2025	Meritage Portfolio Management	41,021	$1.96M	0.1%	-32.1%	0.073%
10/27/2025	Polaris Capital Management LLC	25,800	$1.23M	0.1%	-40.1%	0.046%
10/24/2025	New York State Teachers Retirement System	85,376	$4.08M	0.0%	-0.4%	0.152%
10/24/2025	Oregon Public Employees Retirement Fund	12,598	$0.60M	0.0%	-1.6%	0.022%
10/24/2025	State of Alaska Department of Revenue	31,160	$1.49M	0.0%	-6.5%	0.056%
10/23/2025	SG Americas Securities LLC	10,353	$0.50M	0.0%	-51.7%	0.018%
10/23/2025	KLP Kapitalforvaltning AS	34,600	$1.65M	0.0%	-17.0%	0.062%
10/22/2025	Louisiana State Employees Retirement System	25,800	$1.23M	0.0%	-1.5%	0.046%
10/22/2025	NDVR Inc.	4,324	$0.21M	0.2%	N/A	0.008%
10/22/2025	Hennion & Walsh Asset Management Inc.	101,740	$4.86M	0.2%	+7.3%	0.181%
10/20/2025	VIRGINIA RETIREMENT SYSTEMS ET Al	28,236	$1.35M	0.0%	-42.1%	0.050%
10/16/2025	Rice Hall James & Associates LLC	476,081	$22.75M	1.2%	-9.3%	0.849%
10/16/2025	Burney Co.	8,038	$0.38M	0.0%	-3.0%	0.014%
10/15/2025	CWM LLC	3,656	$0.18M	0.0%	+18.7%	0.007%
10/15/2025	Pacer Advisors Inc.	190,894	$9.12M	0.0%	-33.8%	0.340%
10/14/2025	Yousif Capital Management LLC	17,571	$0.84M	0.0%	-16.5%	0.031%
10/14/2025	Exchange Traded Concepts LLC	17,550	$0.84M	0.0%	-30.8%	0.031%
10/10/2025	USA Financial Formulas	1,051	$50K	0.0%	N/A	0.002%
10/10/2025	Wedge Capital Management L L P NC	69,581	$3.33M	0.1%	-5.8%	0.124%
10/9/2025	Kennebec Savings Bank	1,978	$95K	0.1%	-40.1%	0.004%
10/9/2025	Voya Investment Management LLC	47,613	$2.28M	0.0%	-20.3%	0.085%
10/9/2025	Contravisory Investment Management Inc.	6,203	$0.30M	0.1%	N/A	0.011%
10/2/2025	GAMMA Investing LLC	5,932	$0.28M	0.0%	+107.3%	0.011%
10/1/2025	Praxis Investment Management Inc.	5,090	$0.24M	0.0%	N/A	0.009%
9/26/2025	Corient Private Wealth LLC	7,728	$0.25M	0.0%	N/A	0.014%
9/24/2025	Texas Permanent School Fund Corp	24,423	$0.77M	0.0%	-3.8%	0.044%
9/4/2025	Osaic Holdings Inc.	1,956	$63K	0.0%	+211.5%	0.003%
8/28/2025	China Universal Asset Management Co. Ltd.	21,245	$0.67M	0.1%	+9.8%	0.038%
8/27/2025	Orion Porfolio Solutions LLC	12,541	$0.40M	0.0%	-1.8%	0.022%
8/27/2025	Squarepoint Ops LLC	119,978	$3.78M	0.0%	+63.8%	0.214%
8/26/2025	Thrivent Financial for Lutherans	41,170	$1.30M	0.0%	+1.5%	0.073%
8/19/2025	Pitcairn Co.	7,737	$0.24M	0.0%	-15.3%	0.014%
8/18/2025	Ashford Capital Management Inc.	574,372	$18.10M	2.1%	+1.4%	1.024%
8/16/2025	Public Sector Pension Investment Board	220,304	$6.94M	0.0%	+0.3%	0.393%
8/15/2025	CANADA LIFE ASSURANCE Co	61,936	$1.95M	0.0%	+5.7%	0.110%
8/15/2025	Tower Research Capital LLC TRC	4,245	$0.13M	0.0%	+255.5%	0.008%
8/15/2025	Corient Private Wealth LLC	7,728	$0.25M	0.0%	N/A	0.014%
8/15/2025	Krensavage Asset Management LLC	472,376	$14.89M	7.9%	+9.3%	0.842%
8/15/2025	Captrust Financial Advisors	20,412	$0.64M	0.0%	+15.1%	0.036%
8/15/2025	Vident Advisory LLC	14,250	$0.45M	0.0%	-4.3%	0.025%
8/15/2025	Smartleaf Asset Management LLC	869	$27K	0.0%	-24.9%	0.002%
8/15/2025	Sofinnova Investments Inc.	799,253	$25.19M	1.5%	+53.5%	1.425%
8/15/2025	Rubric Capital Management LP	695,039	$21.91M	0.3%	N/A	1.240%
8/15/2025	Orion Porfolio Solutions LLC	12,541	$0.40M	0.0%	-1.8%	0.022%
8/15/2025	Man Group plc	64,744	$2.04M	0.0%	+59.4%	0.115%
8/15/2025	Lazard Asset Management LLC	111,399	$3.51M	0.0%	+394.7%	0.199%
8/15/2025	Engineers Gate Manager LP	22,963	$0.72M	0.0%	+27.3%	0.041%
8/15/2025	BNP Paribas Financial Markets	302,665	$9.54M	0.0%	+16.4%	0.540%
8/15/2025	Bridgeway Capital Management LLC	121,900	$3.84M	0.1%	+83.6%	0.217%
8/15/2025	Brevan Howard Capital Management LP	36,105	$1.14M	0.0%	+11.4%	0.064%
8/15/2025	Bank of America Corp DE	504,306	$15.90M	0.0%	+4.4%	0.899%
8/15/2025	Ameriprise Financial Inc.	173,175	$5.46M	0.0%	-61.7%	0.309%
8/15/2025	AQR Capital Management LLC	140,557	$4.43M	0.0%	+64.9%	0.251%
8/14/2025	PDT Partners LLC	94,307	$2.97M	0.2%	+152.3%	0.168%
8/14/2025	Jane Street Group LLC	18,639	$0.59M	0.0%	-83.2%	0.033%
8/14/2025	Raymond James Financial Inc.	1,756	$55K	0.0%	N/A	0.003%

Data available starting January 2016

Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. The company's commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prophylaxis of migraine headache; and Oxtellar XR, an extended release oxcarbazepine for the monotherapy treatment of partial onset seizures in adults and children between 6 to 17 years of age. It also offers comprise Qelbree, a novel non-stimulant indicated for the treatment of attention-deficit hyperactivity disorder (ADHD) in adults and pediatric patients 6 years and older; APOKYN for the acute intermittent treatment of hypomobility or off episodes in patients with advanced Parkinson's Disease (PD); XADAGO for treating levodopa/carbidopa in patients with PD experiencing off episodes; MYOBLOC, a Type B toxin product indicated for the treatment of cervical dystonia and sialorrhea in adults; GOCOVRI for the treatment of dyskinesia in patients with PD; and Osmolex ER for the treatment of Parkinson's disease and drug-induced extrapyramidal reaction in adult patients. In addition, the company's product candidates include SPN-830, a late-stage drug/device combination product candidate for the treatment of off episodes in PD patients; SPN-817, a novel first-in-class selective acetylcholinesterase inhibitor, which is in Phase II clinical trials for the treatment of epilepsy; SPN-820, a product candidate in Phase II clinical trials for treating resistant depression; SPN-443, a preclinical product for the treatment of ADHD/CNS; and SPN-446 for narcolepsy and SPN-448 for the treatment of CNS which is in discovery stage. It markets and sells its products through pharmaceutical wholesalers, specialty pharmacies, and distributors. Supernus Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Rockville, Maryland.

Today's Range

Now: $45.40

$44.51

$46.53

50 Day Range

MA: $48.60

$43.99

$57.00

52 Week Range

Now: $45.40

$29.16

$57.65

Volume

1,094,154 shs

Average Volume

689,760 shs

Market Capitalization

$2.55 billion

P/E Ratio

39.48

Dividend Yield

N/A

Beta

0.75

Who are the company insiders with the largest holdings of Supernus Pharmaceuticals?: Supernus Pharmaceuticals' top insider investors include:
Jack A Khattar (CEO)
Tami Tillotson Martin (VP)
Frederick M Hudson (Director)
Frank Mottola (SVP)
Georges Gemayel (Director)
Padmanabh P Bhatt (VP)
Jonathan Rubin (SVP)
Timothy C Dec (CFO)
Bethany Sensenig (Director)
Learn More about top insider investors at Supernus Pharmaceuticals.
Who are the major institutional investors of Supernus Pharmaceuticals?: Supernus Pharmaceuticals' top institutional investors include:
Vanguard Group Inc. — 10.78%
Stephens Investment Management Group LLC — 2.40%
Rice Hall James & Associates LLC — 0.85%
Principal Financial Group Inc. — 0.54%
Public Sector Pension Investment Board — 0.39%
Mutual of America Capital Management LLC — 0.36%
Learn More about top institutional investors of Supernus Pharmaceuticals stock.
Which major investors are selling Supernus Pharmaceuticals stock?: In the last quarter, SUPN stock was sold by these institutional investors:
Stephens Investment Management Group LLC
Vanguard Group Inc.
JPMorgan Chase & Co.
Pacer Advisors Inc.
Great Lakes Advisors LLC
Envestnet Asset Management Inc.
Rice Hall James & Associates LLC
VIRGINIA RETIREMENT SYSTEMS ET Al
Within the last year, company insiders that have sold Supernus Pharmaceuticals company stock include:
Jack A Khattar (CEO)
Tami Tillotson Martin (VP)
Frederick M Hudson (Director)
Frank Mottola (SVP)
Georges Gemayel (Director)
Padmanabh P Bhatt (VP)
Jonathan Rubin (SVP)
Learn More investors selling Supernus Pharmaceuticals stock.
Which major investors are buying Supernus Pharmaceuticals stock?: In the last quarter, SUPN stock was bought by institutional investors including:
Teacher Retirement System of Texas
Ruffer LLP
VELA Investment Management LLC
Universal Beteiligungs und Servicegesellschaft mbH
AdvisorShares Investments LLC
Castlekeep Investment Advisors LLC
Hennion & Walsh Asset Management Inc.
Contravisory Investment Management Inc.